Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections
Antibiotic resistance is already widespread in the world, and it has become a great health problem. Therefore, comprehensive efforts are needed to minimize the resistance. The exploration of alternative therapies may offer a more targeted approach with less susceptibility to resistance. Even though...
Gespeichert in:
| Veröffentlicht in: | Current microbiology 2022-04, Vol.79 (4), p.102-102, Article 102 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 102 |
|---|---|
| container_issue | 4 |
| container_start_page | 102 |
| container_title | Current microbiology |
| container_volume | 79 |
| creator | Askari, Parvin Yousefi, Masoud Foadoddini, Mohsen Neshani, Alireza Aganj, Mahdi Lotfi, Nasim Movaqar, Aref Ghazvini, Kiarash Namaei, Mohammad Hasan |
| description | Antibiotic resistance is already widespread in the world, and it has become a great health problem. Therefore, comprehensive efforts are needed to minimize the resistance. The exploration of alternative therapies may offer a more targeted approach with less susceptibility to resistance. Even though antimicrobial peptides (AMPs) have been introduced as emerging antibiotic sources, they are not widely discussed in the literature. Since
Neisseria
infections show resistance to different types of antibiotics, the purpose of this review was to discuss the currently investigated AMPs with anti-
Neisseria
properties. In the present review, we provide an overview of 24 AMPs with in vitro anti-
Neisseria
properties. |
| doi_str_mv | 10.1007/s00284-022-02767-y |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2628685587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2628212247</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-2f56d3e017dc2426a114ab71a4126726d6fbaa27a912a213377f1f3427834f253</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMouq7-AQ9S8OKlmpmkSXtcxC9YdEE9h2ybrJF-rEl76L83uquCByFDCPPMm-Eh5AToBVAqLwOlmPOUIsaSQqbjDpkAZ_FZFLBLJpRxluYigwNyGMIbpYAFhX1ywDLIkEExIU-ztneNK323dLpOFmbdu8qERMeTLHzXuODaVfL8arxem6F3ZfLUe92b1ZjYzicPxoVgvNPJfWtN2buuDUdkz-o6mOPtPSUvN9fPV3fp_PH2_mo2T0smsz5Fm4mKGQqyKpGj0ABcLyVoDigkikrYpdYodQGoERiT0oJlHGXOuMWMTcn5Jnftu_fBhF7FbUtT17o13RAUCsxFnmW5jOjZH_StG3wbt_uiEBD5J4UbKuoIwRur1t412o8KqPpUrjbKVVSuvpSrMQ6dbqOHZWOqn5FvxxFgGyDEVrsy_vfvf2I_AMb2iz0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2628212247</pqid></control><display><type>article</type><title>Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Askari, Parvin ; Yousefi, Masoud ; Foadoddini, Mohsen ; Neshani, Alireza ; Aganj, Mahdi ; Lotfi, Nasim ; Movaqar, Aref ; Ghazvini, Kiarash ; Namaei, Mohammad Hasan</creator><creatorcontrib>Askari, Parvin ; Yousefi, Masoud ; Foadoddini, Mohsen ; Neshani, Alireza ; Aganj, Mahdi ; Lotfi, Nasim ; Movaqar, Aref ; Ghazvini, Kiarash ; Namaei, Mohammad Hasan</creatorcontrib><description>Antibiotic resistance is already widespread in the world, and it has become a great health problem. Therefore, comprehensive efforts are needed to minimize the resistance. The exploration of alternative therapies may offer a more targeted approach with less susceptibility to resistance. Even though antimicrobial peptides (AMPs) have been introduced as emerging antibiotic sources, they are not widely discussed in the literature. Since
Neisseria
infections show resistance to different types of antibiotics, the purpose of this review was to discuss the currently investigated AMPs with anti-
Neisseria
properties. In the present review, we provide an overview of 24 AMPs with in vitro anti-
Neisseria
properties.</description><identifier>ISSN: 0343-8651</identifier><identifier>EISSN: 1432-0991</identifier><identifier>DOI: 10.1007/s00284-022-02767-y</identifier><identifier>PMID: 35152319</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibiotic resistance ; Antibiotics ; Antiinfectives and antibacterials ; Antimicrobial agents ; Antimicrobial Cationic Peptides - pharmacology ; Antimicrobial Peptides ; Biomedical and Life Sciences ; Biotechnology ; Drug Resistance, Microbial ; Life Sciences ; Microbiology ; Neisseria ; Peptides ; Review Article</subject><ispartof>Current microbiology, 2022-04, Vol.79 (4), p.102-102, Article 102</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022</rights><rights>2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-2f56d3e017dc2426a114ab71a4126726d6fbaa27a912a213377f1f3427834f253</citedby><cites>FETCH-LOGICAL-c375t-2f56d3e017dc2426a114ab71a4126726d6fbaa27a912a213377f1f3427834f253</cites><orcidid>0000-0003-2889-8273</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00284-022-02767-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00284-022-02767-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35152319$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Askari, Parvin</creatorcontrib><creatorcontrib>Yousefi, Masoud</creatorcontrib><creatorcontrib>Foadoddini, Mohsen</creatorcontrib><creatorcontrib>Neshani, Alireza</creatorcontrib><creatorcontrib>Aganj, Mahdi</creatorcontrib><creatorcontrib>Lotfi, Nasim</creatorcontrib><creatorcontrib>Movaqar, Aref</creatorcontrib><creatorcontrib>Ghazvini, Kiarash</creatorcontrib><creatorcontrib>Namaei, Mohammad Hasan</creatorcontrib><title>Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections</title><title>Current microbiology</title><addtitle>Curr Microbiol</addtitle><addtitle>Curr Microbiol</addtitle><description>Antibiotic resistance is already widespread in the world, and it has become a great health problem. Therefore, comprehensive efforts are needed to minimize the resistance. The exploration of alternative therapies may offer a more targeted approach with less susceptibility to resistance. Even though antimicrobial peptides (AMPs) have been introduced as emerging antibiotic sources, they are not widely discussed in the literature. Since
Neisseria
infections show resistance to different types of antibiotics, the purpose of this review was to discuss the currently investigated AMPs with anti-
Neisseria
properties. In the present review, we provide an overview of 24 AMPs with in vitro anti-
Neisseria
properties.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Antiinfectives and antibacterials</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial Cationic Peptides - pharmacology</subject><subject>Antimicrobial Peptides</subject><subject>Biomedical and Life Sciences</subject><subject>Biotechnology</subject><subject>Drug Resistance, Microbial</subject><subject>Life Sciences</subject><subject>Microbiology</subject><subject>Neisseria</subject><subject>Peptides</subject><subject>Review Article</subject><issn>0343-8651</issn><issn>1432-0991</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kE1LxDAQhoMouq7-AQ9S8OKlmpmkSXtcxC9YdEE9h2ybrJF-rEl76L83uquCByFDCPPMm-Eh5AToBVAqLwOlmPOUIsaSQqbjDpkAZ_FZFLBLJpRxluYigwNyGMIbpYAFhX1ywDLIkEExIU-ztneNK323dLpOFmbdu8qERMeTLHzXuODaVfL8arxem6F3ZfLUe92b1ZjYzicPxoVgvNPJfWtN2buuDUdkz-o6mOPtPSUvN9fPV3fp_PH2_mo2T0smsz5Fm4mKGQqyKpGj0ABcLyVoDigkikrYpdYodQGoERiT0oJlHGXOuMWMTcn5Jnftu_fBhF7FbUtT17o13RAUCsxFnmW5jOjZH_StG3wbt_uiEBD5J4UbKuoIwRur1t412o8KqPpUrjbKVVSuvpSrMQ6dbqOHZWOqn5FvxxFgGyDEVrsy_vfvf2I_AMb2iz0</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Askari, Parvin</creator><creator>Yousefi, Masoud</creator><creator>Foadoddini, Mohsen</creator><creator>Neshani, Alireza</creator><creator>Aganj, Mahdi</creator><creator>Lotfi, Nasim</creator><creator>Movaqar, Aref</creator><creator>Ghazvini, Kiarash</creator><creator>Namaei, Mohammad Hasan</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2889-8273</orcidid></search><sort><creationdate>20220401</creationdate><title>Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections</title><author>Askari, Parvin ; Yousefi, Masoud ; Foadoddini, Mohsen ; Neshani, Alireza ; Aganj, Mahdi ; Lotfi, Nasim ; Movaqar, Aref ; Ghazvini, Kiarash ; Namaei, Mohammad Hasan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-2f56d3e017dc2426a114ab71a4126726d6fbaa27a912a213377f1f3427834f253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Antiinfectives and antibacterials</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial Cationic Peptides - pharmacology</topic><topic>Antimicrobial Peptides</topic><topic>Biomedical and Life Sciences</topic><topic>Biotechnology</topic><topic>Drug Resistance, Microbial</topic><topic>Life Sciences</topic><topic>Microbiology</topic><topic>Neisseria</topic><topic>Peptides</topic><topic>Review Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Askari, Parvin</creatorcontrib><creatorcontrib>Yousefi, Masoud</creatorcontrib><creatorcontrib>Foadoddini, Mohsen</creatorcontrib><creatorcontrib>Neshani, Alireza</creatorcontrib><creatorcontrib>Aganj, Mahdi</creatorcontrib><creatorcontrib>Lotfi, Nasim</creatorcontrib><creatorcontrib>Movaqar, Aref</creatorcontrib><creatorcontrib>Ghazvini, Kiarash</creatorcontrib><creatorcontrib>Namaei, Mohammad Hasan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Current microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Askari, Parvin</au><au>Yousefi, Masoud</au><au>Foadoddini, Mohsen</au><au>Neshani, Alireza</au><au>Aganj, Mahdi</au><au>Lotfi, Nasim</au><au>Movaqar, Aref</au><au>Ghazvini, Kiarash</au><au>Namaei, Mohammad Hasan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections</atitle><jtitle>Current microbiology</jtitle><stitle>Curr Microbiol</stitle><addtitle>Curr Microbiol</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>79</volume><issue>4</issue><spage>102</spage><epage>102</epage><pages>102-102</pages><artnum>102</artnum><issn>0343-8651</issn><eissn>1432-0991</eissn><abstract>Antibiotic resistance is already widespread in the world, and it has become a great health problem. Therefore, comprehensive efforts are needed to minimize the resistance. The exploration of alternative therapies may offer a more targeted approach with less susceptibility to resistance. Even though antimicrobial peptides (AMPs) have been introduced as emerging antibiotic sources, they are not widely discussed in the literature. Since
Neisseria
infections show resistance to different types of antibiotics, the purpose of this review was to discuss the currently investigated AMPs with anti-
Neisseria
properties. In the present review, we provide an overview of 24 AMPs with in vitro anti-
Neisseria
properties.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>35152319</pmid><doi>10.1007/s00284-022-02767-y</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-2889-8273</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0343-8651 |
| ispartof | Current microbiology, 2022-04, Vol.79 (4), p.102-102, Article 102 |
| issn | 0343-8651 1432-0991 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2628685587 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibiotic resistance Antibiotics Antiinfectives and antibacterials Antimicrobial agents Antimicrobial Cationic Peptides - pharmacology Antimicrobial Peptides Biomedical and Life Sciences Biotechnology Drug Resistance, Microbial Life Sciences Microbiology Neisseria Peptides Review Article |
| title | Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A26%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20Peptides%20as%20a%20Promising%20Therapeutic%20Strategy%20for%20Neisseria%20Infections&rft.jtitle=Current%20microbiology&rft.au=Askari,%20Parvin&rft.date=2022-04-01&rft.volume=79&rft.issue=4&rft.spage=102&rft.epage=102&rft.pages=102-102&rft.artnum=102&rft.issn=0343-8651&rft.eissn=1432-0991&rft_id=info:doi/10.1007/s00284-022-02767-y&rft_dat=%3Cproquest_cross%3E2628212247%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2628212247&rft_id=info:pmid/35152319&rfr_iscdi=true |